As of Jul 22
| +1.01 / +1.44%|
The 4 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 68.00, with a high estimate of 86.00 and a low estimate of 60.00. The median estimate represents a -4.53% decrease from the last price of 71.23.
The current consensus among 6 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.